These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9202237)

  • 41. Sex difference in the action of activin-A on cell proliferation of differentiating rat gonad.
    Kaipia A; Toppari J; Huhtaniemi I; Paranko J
    Endocrinology; 1994 May; 134(5):2165-70. PubMed ID: 8156918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan-glycan.
    Gray PC; Bilezikjian LM; Vale W
    Mol Cell Endocrinol; 2001 Jun; 180(1-2):47-53. PubMed ID: 11451571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
    Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
    Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of activin-A, inhibin-A, and transforming growth factor-beta 1 on stage-specific deoxyribonucleic acid synthesis during rat seminiferous epithelial cycle.
    Hakovirta H; Kaipia A; Söder O; Parvinen M
    Endocrinology; 1993 Oct; 133(4):1664-8. PubMed ID: 8404607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activins and inhibins and their signaling.
    Vale W; Wiater E; Gray P; Harrison C; Bilezikjian L; Choe S
    Ann N Y Acad Sci; 2004 Dec; 1038():142-7. PubMed ID: 15838109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a binding site on the type II activin receptor for activin and inhibin.
    Gray PC; Greenwald J; Blount AL; Kunitake KS; Donaldson CJ; Choe S; Vale W
    J Biol Chem; 2000 Feb; 275(5):3206-12. PubMed ID: 10652306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
    Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
    Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth differentiation factor 9 enhances activin a-induced inhibin B production in human granulosa cells.
    Shi FT; Cheung AP; Leung PC
    Endocrinology; 2009 Aug; 150(8):3540-6. PubMed ID: 19423755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular biology of inhibin action.
    Cook RW; Thompson TB; Jardetzky TS; Woodruff TK
    Semin Reprod Med; 2004 Aug; 22(3):269-76. PubMed ID: 15319829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical localization and mRNA expression of activin, inhibin, follistatin, and activin receptor in bovine cumulus-oocyte complexes during in vitro maturation.
    Izadyar F; Dijkstra G; Van Tol HT; Van den Eijnden-van Raaij AJ; Van den Hurk R; Colenbrander B; Bevers MM
    Mol Reprod Dev; 1998 Feb; 49(2):186-95. PubMed ID: 9444661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural basis for a functional antagonist in the transforming growth factor beta superfamily.
    Cook RW; Thompson TB; Kurup SP; Jardetzky TS; Woodruff TK
    J Biol Chem; 2005 Dec; 280(48):40177-86. PubMed ID: 16186117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The regulation of apoptosis by activin and transforming growth factor-beta in early neoplastic and tumorigenic ovarian surface epithelium.
    Choi KC; Kang SK; Tai CJ; Auersperg N; Leung PC
    J Clin Endocrinol Metab; 2001 May; 86(5):2125-35. PubMed ID: 11344217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of activin's access to the cell: why is mother nature such a control freak?
    Phillips DJ
    Bioessays; 2000 Aug; 22(8):689-96. PubMed ID: 10918299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system.
    del Re E; Sidis Y; Fabrizio DA; Lin HY; Schneyer A
    J Biol Chem; 2004 Dec; 279(51):53126-35. PubMed ID: 15475360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan.
    Gray PC; Bilezikjian LM; Vale W
    Mol Cell Endocrinol; 2002 Feb; 188(1-2):254-60. PubMed ID: 11911962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibin binding protein (InhBP/p120), betaglycan, and the continuing search for the inhibin receptor.
    Bernard DJ; Chapman SC; Woodruff TK
    Mol Endocrinol; 2002 Feb; 16(2):207-12. PubMed ID: 11818494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibin: actions and signalling.
    Phillips DJ; Woodruff TK
    Growth Factors; 2004 Mar; 22(1):13-8. PubMed ID: 15176454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of activin type I receptor function by phosphorylation of residues outside the GS domain.
    Willis SA; Mathews LS
    FEBS Lett; 1997 Dec; 420(2-3):117-20. PubMed ID: 9459292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In search of binding--identification of inhibin receptors.
    Matzuk MM
    Endocrinology; 2000 Jul; 141(7):2281-4. PubMed ID: 10875226
    [No Abstract]   [Full Text] [Related]  

  • 60. Cloning and characterization of goldfish activin type IIB receptor.
    Ge W; Tanaka M; Yoshikuni M; Eto Y; Nagahama Y
    J Mol Endocrinol; 1997 Aug; 19(1):47-57. PubMed ID: 9278860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.